Evaluation of proliferative activity of brain tumors using Ki-67 LI*AgNORs

被引：0
|
作者：
Nakabayashi, H
Sunada, I
Hakuba, A
机构：
来源：
11TH INTERNATIONAL CONGRESS OF NEUROLOGICAL SURGERY, VOLS 1 AND 2 | 1997年
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Ki-67 LI*AgNORs was evaluated in 92 brain tumors. The mean scores of Ki-67 LI*AgNORs were as follows: glioblastoma 59.4; anaplastic astrocytoma 22.4; low grade astrocytoma 4.60; recurrent meningioma 7.87; non-recurrent meningioma 1.52; pituitary adenoma 1.85; acoustic neurinoma 1.47. A statistically significant differrence in Ki-67 LI*AgNORs was observed between glioblastomas, high grade gliomas and low grade gliomas (p<0.005). A statistically significant differrence in Ki-67 LI*AgNORs was observed between recurrent meningiomas and non-recurrent meningiomas (p<0.005). In meningiomas, Ki-67 LI*AgNORs was a useful parameter for discriminating between recurrent and non-recurrent group. Ki-67 LI*AgNORs may serve as a useful prognostic indicator in brain tumors.
引用
收藏
页码：609 / 611
页数：3
相关论文
共 50 条
  • [1] PROLIFERATIVE ACTIVITY IN PARATHYROID TUMORS AS DETECTED BY KI-67 IMMUNOSTAINING
    ABBONA, GC
    PAPOTTI, M
    GASPARRI, G
    BUSSOLATI, G
    [J]. HUMAN PATHOLOGY, 1995, 26 (02) : 135 - 138
  • [2] EVALUATION OF PROLIFERATIVE ACTIVITY IN HUMAN HEAD AND NECK TUMORS USING THE MONOCLONAL-ANTIBODY KI-67
    LORZ, M
    MEYERBREITING, E
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1988, 50 (03): : 183 - 187
  • [3] Significance of AgNORs and Ki-67 Proliferative Markers in Differential Diagnosis of Thyroid Lesions
    Aiad, Hayam A.
    Bashandy, Manar A.
    Abdou, Asmaa G.
    Zahran, Ahmad A.
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (02) : 167 - 175
  • [4] Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
    Fasanella, S.
    Leonardi, E.
    Cantaloni, C.
    Eccher, C.
    Bazzanella, I.
    Aldovini, D.
    Bragantini, E.
    Morelli, L.
    Cuorvo, L. V.
    Ferro, A.
    Gasperetti, F.
    Berlanda, G.
    Dalla Palma, P.
    Barbareschi, M.
    [J]. DIAGNOSTIC PATHOLOGY, 2011, 6
  • [5] Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
    S Fasanella
    E Leonardi
    C Cantaloni
    C Eccher
    I Bazzanella
    D Aldovini
    E Bragantini
    L Morelli
    LV Cuorvo
    A Ferro
    F Gasperetti
    G Berlanda
    P Dalla Palma
    M Barbareschi
    [J]. Diagnostic Pathology, 6
  • [6] Simple hyperplasia of the endometrium: An evaluation of proliferative activity by Ki-67 immunostaining
    Ambros, RA
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2000, 19 (03) : 206 - 211
  • [7] DETERMINATION OF THE PROLIFERATIVE POTENTIAL OF HUMAN-BRAIN TUMORS USING THE MONOCLONAL-ANTIBODY KI-67
    DECKERT, M
    REIFENBERGER, G
    WECHSLER, W
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (02) : 179 - 188
  • [8] Proliferative activity in human breast cancer: assessment of Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
    Bragantini, E.
    Fasanella, S.
    Eccher, C.
    Leonardi, E.
    Aldovini, D.
    Morelli, L.
    Ferro, A.
    Cuorvo, L. V.
    Dalla Palma, P.
    Barbareschi, M.
    [J]. VIRCHOWS ARCHIV, 2010, 457 (02) : 168 - 168
  • [9] Assessment of proliferative activity of thyroid Hurthle cell tumors using PCNA, Ki-67 and AgNOR methods
    Augustynowicz, A
    Dzieciol, J
    Barwijuk-Machala, M
    Dadan, J
    Puchalski, Z
    Sulkowski, S
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2004, 42 (03) : 165 - 168
  • [10] Significance of Ki-67 Proliferative Index in Midgut Carcinoid Tumors
    Dhall, D.
    Dhall, G.
    Ines, D.
    Chung, F.
    Kim, A.
    Colqhoun, S. D.
    Mirocha, J.
    Wang, H. L.
    [J]. MODERN PATHOLOGY, 2009, 22 : 116A - 116A
12345